Stay updated on Clinical Trial: Vyvanse Onset Time in ADHD Children
Sign up to get notified when there's something new on the Clinical Trial: Vyvanse Onset Time in ADHD Children page.

Latest updates to the Clinical Trial: Vyvanse Onset Time in ADHD Children page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record presents details of the completed pediatric Vyvanse ADHD study, including its design, eligibility criteria, locations, outcome measures, and publication and record history.SummaryDifference46%

- Check17 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0; the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study page remains a 403 error page.SummaryDifference1%

- Check38 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now displays a 403 Forbidden error page, replacing the usual content and including a Home link, signaling that the page cannot be accessed at this time.SummaryDifference0.5%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error, providing minimal navigation (a Home link) and replacing the study record content with an error state. As a result, the full study content and related sections are no longer accessible on the page.SummaryDifference17%

Stay in the know with updates to Clinical Trial: Vyvanse Onset Time in ADHD Children
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Vyvanse Onset Time in ADHD Children page.